CM Life Sciences, Inc. (CMLFU) は上場企業です 金融 セクターの Shell Companies 業界で事業展開. 本社所在地は New York City, NY, アメリカ. 現CEOは Eli Decatur Casdin.
CMLFU を有する IPO日 2020-09-02, に上場 NASDAQ Capital Marke, 時価総額 $10.31B.
CM Life Sciences, Inc. is a special purpose acquisition company (SPAC) founded in 2020 and headquartered in New York, New York. The company was established to identify and execute a merger or business combination with one or more operating companies, potentially involving capital stock exchanges, asset acquisitions, or stock purchases. Through this acquisition strategy, CM Life Sciences seeks to create value in the life sciences sector by combining with established or emerging businesses.
